Brief: Medicus Pharma Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT in Patients with Gorlin Syndrome

Medicus Pharma

29/10/2025 12:52

Oct 29 (Reuters) - Medicus Pharma Ltd MDCX.O:

MEDICUS PHARMA LTD. ANNOUNCES COLLABORATION WITH THE GORLIN SYNDROME ALLIANCE TO PURSUE COMPASSIONATE USE PATHWAY FOR SKINJECT™ IN PATIENTS WITH GORLIN SYNDROME

MEDICUS PHARMA LTD - AND GSA TO PURSUE EXPANDED ACCESS IND PROGRAM WITH FDA

Source text: ID:nGNX45fQ8r

Further company coverage: MDCX.O

 ((Reuters.Briefs@thomsonreuters.com;))